These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 6119668

  • 1. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M, Tarján J, Wágner G, Rostás L, Lascsik L, Kovács S, Parti G.
    Orv Hetil; 1981 Oct 11; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract] [Full Text] [Related]

  • 2. [Essential circulatory hyperkinesis and tobanum].
    Nagy I.
    Orv Hetil; 1982 Feb 28; 123(9):569. PubMed ID: 6123100
    [No Abstract] [Full Text] [Related]

  • 3. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E, Istvánffy M, Halmágyi M, Wagner M, Csukás M.
    Int J Clin Pharmacol Ther Toxicol; 1980 Feb 28; 18(5):200-7. PubMed ID: 6104634
    [Abstract] [Full Text] [Related]

  • 4. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
    Szám I, Büky P, Gulyás A, Sinkovics M.
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar 28; 20(3):128-33. PubMed ID: 6121761
    [Abstract] [Full Text] [Related]

  • 5. [Hyperkinetic heart syndrome].
    Linss G.
    Z Arztl Fortbild (Jena); 1985 Mar 28; 79(2):63-5. PubMed ID: 2859706
    [No Abstract] [Full Text] [Related]

  • 6. Roentgen patterns of essential circulatory hyperkinesis.
    Csákány G, Varga L.
    Radiol Diagn (Berl); 1965 Mar 28; 6(5):533-7. PubMed ID: 5882508
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z, Hollósi Z, Iskum M.
    Ther Hung; 1984 Mar 28; 32(2):74-8. PubMed ID: 6152819
    [No Abstract] [Full Text] [Related]

  • 12. Editorial: Da Costa syndrome revisited.
    Vaisrub S.
    JAMA; 1975 Apr 14; 232(2):164. PubMed ID: 235031
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Length of effect of beta-blockers in hyperkinetic heart syndrome].
    Paulsen HF, Felder K.
    ZFA (Stuttgart); 1983 Jul 20; 59(20):1149-54. PubMed ID: 6137915
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of vegetovascular dystonia with beta-blockaders and tranquilizers].
    Zubarev IuG, Kulakov SA.
    Sov Med; 1985 Jul 20; (3):83-5. PubMed ID: 2862710
    [No Abstract] [Full Text] [Related]

  • 18. [Indications for beta-blockers in other cardiac diseases: rhythm disorders, obstructive cardiomyopathy, cardiothyreosis and neurocirculatory asthenia].
    Guize L, Le Heuzey JY.
    Rev Prat; 1984 Apr 01; 34(19):967-72. PubMed ID: 6144163
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.